Feedback / Questions
gemcitabine/docetaxel controlled release (NDV-01) - Relmada Therapeutics
https://www.globenewswire.com/news-release/2025/04/24/3067358/0/en/Relmada-Therapeutics-to-Host-KOL-Event-on-Phase-2-NDV-01-Data.html
Apr 24, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next